Terminated PHASE2 INTERVENTIONAL 1-arm NCT00271947

Crohn's Disease Stem Cell Transplantation

Crohn's Disease Non-myeloablative Autologous Hematopoietic Stem Cell Transplantation (CDNST) Versus Standard Therapy

Sponsor: Northwestern University

Interventions Autologous Stem Cell Transplantation

Updated 7 times since 2017 Last updated: Feb 10, 2014 Started: Apr 30, 2005 Primary completion: Apr 30, 2012 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The PI, who was sponsor got retired

Other terminated trials from Northwestern University

See all terminations from Northwestern University

Other Crohn's Disease trials with similar outcome

Browse all Crohn's Disease trials

This PHASE2 trial investigates Crohn's Disease and is currently terminated or withdrawn. Northwestern University leads this study, which shows 7 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Dec 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jan 2021 — Dec 2021 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Terminated PHASE2
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE2

First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Northwestern University

Data source: Northwestern University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States